Keywords: new, indications, oked, genzyme, synvisc, usa-based, received

New indications OKed for Genzyme's Synvisc

Article | 09 October 2006

Print This

USA-based Genzyme has received European Union approval to expand the CE mark labeling for Synvisc (hylan G-F 20) to include treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in